TickerFactsScreenerDevelopers

Cartesian Therapeutics, Inc. (RNAC) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $8.06M2014: $16.59M2015: $32.34M2016: $58.66M2017: $70.62M2018: $37.40M2019: $89.89M2020: $138.69M2021: $114.06M2022: $106.44M2023: $76.91M2024: $212.61M2025: $125.14M$125.14M
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$125.14M-41.1%
2024$212.61M+176.4%
2023$76.91M-27.7%
2022$106.44M-6.7%
2021$114.06M-17.8%
2020$138.69M+54.3%
2019$89.89M+140.3%
2018$37.40M-47.0%
2017$70.62M+20.4%
2016$58.66M+81.4%
2015$32.34M+94.9%
2014$16.59M+105.9%
2013$8.06M—